P&G Antiarrhythmia Drug Successful in Trial
123871
An experimental Procter & Gamble  antiarrhythmia drug significantly reduced the number of painful  and unpleasant shocks to patients with implanted defibrillators  in a late-stage clinical trial.
118689
The anti-impotence drug could be a good treatment for heart failure, US researchers believe.
468910
Biomira reports favorable Phase II test results.
658531
A federal appeals court has cleared  the way for Alpharma Inc. ALO.N to launch a generic form of  Pfizer Inc.'s PFE.N Neurontin capsules to treat epilepsy,  sending Alpharma shares sharply higher.
303689
Acorda announces positive clinical trial data.
395304
AtheroGenics Inc.(AGIX.O: Quote, Profile, Research) said on Monday its AGI-1067 experimental drug showed positive interim results during a Phase IIb trial for treating the hardening of the arteries, sending the shares 60
32168
Australian biotech group Metabolic Pharmaceuticals Ltd. said on Monday a clinical trial showed its new weight-loss drug was effective and free of side effects, sending its shares soaring 28 percent.
409429
A new drug from Sanofi-Aventis reduced significantly episodes of atrial fibrillaton or irregular heart beat in two clinical studies released on Sunday.
673697
Encysive Pharmaceuticals on Monday  said its experimental drug to treat an often-fatal lung  condition was effective in a late-stage trial and it appeared  to be safer than the only approved drug for the illness.
747820
FDA approval for the company's colorectal cancer drug is good news for its future prospects.
615315
Encysive Pharmaceuticals on Monday said its experimental drug to treat an often-fatal lung condition was effective in a late-stage trial and it appeared to be safer than the only approved drug for the illness.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
25622
The German biotechnology company Paion and its American partner, Forest Laboratories, announced the outcomes of the trial of its drug, desmoteplase.
121268
EPIX initiates a safety trial and gets good efficacy data.
484469
Pfizer Inc. shares rebounded on  Tuesday as a study of Alzheimer's patients found that its  arthritis drug Celebrex carried no increased cardiovascular  risks, differing from findings of a study in cancer patients  released last week.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
767499
Tablets containing a combination of the blood pressure medication aliskiren and water pill hydrochlorothiazide have been approved by the Food and Drug Administration